Am. J. Respir. Crit. Care Med., Volume 159, Number 1, January 1999, 262-266

Effect of Natural Grass Pollen Exposure on Exhaled Nitric Oxide in Asthmatic Children

EUGENIO BARALDI, SABINA CARRÀ, CINZIA DARIO, NICOLETTA AZZOLIN, RICCARDO ONGARO, GUIDO MARCER, and FRANCO ZACCHELLO

University Department of Pediatrics, Department of Occupational Health, School of Medicine, Padova, Italy

Exhaled nitiric oxide (NO) is increased in exhaled breath of asthmatic patients. The aim of this study was to investigate the longitudinal changes of exhaled NO outside and during the pollen season in pollen-allergic asthmatic children. Twenty-one children (age 6 to 16 yr), with a seasonal allergic asthma sensitive to grass pollen, underwent measurements of exhaled NO and pulmonary function before (March), during (May), and after (November) the pollen season. Exhaled NO was measured by a tidal breathing method with a chemiluminescence analyzer and NO steady-state levels were recorded. The timing of the measurements during the pollen season was based on the atmospheric pollen count. Exhaled NO values of asthmatic children were compared with those of 21 sex- and age-matched healthy children. Pulmonary function and symptoms of asthma were also evaluated at each visit. The mean value of exhaled NO before the grass season was 12.7 ± 5.1 ppb (mean ± SD), significantly higher when compared with controls (7.8 ± 2.7 ppb, p < 0.001). In the pollen season there was a significant (p < 0.001) twofold increase in exhaled NO (21.4 ± 7.6 ppb) that, after the season, returned to values similar (12.8 ± 5.8 ppb, p = NS) to those found before the season. There were no significant changes in FEV₁ before and during the season (98.6% predicted versus 101% predicted, p = NS). We conclude that natural allergen exposure is related to an increase of exhaled NO in asthmatic grass pollen-allergic children even in absence of significant changes in airways function. We speculate that measurement of exhaled NO could be a sensitive noninvasive marker of asthma disease activity.

This article has been cited by other articles:

				G. Rodway, J Choi, L. Hoffman, and J. Sethi Exhaled nitric oxide in the diagnosis and management of asthma: clinical implications Chronic Respiratory Disease, February 1, 2009; 6(1): 19 - 29. [Abstract] [PDF]

				P. Montuschi, C. Mondino, P. Koch, G. Ciabattoni, P. J. Barnes, and G. Baviera Effects of Montelukast Treatment and Withdrawal on Fractional Exhaled Nitric Oxide and Lung Function in Children With Asthma Chest, December 1, 2007; 132(6): 1876 - 1881. [Abstract] [Full Text] [PDF]

				A. Bodini, D. Peroni, A. Loiacono, S. Costella, R. Pigozzi, E. Baraldi, A. L. Boner, and G. L. Piacentini Exhaled Nitric Oxide Daily Evaluation Is Effective in Monitoring Exposure to Relevant Allergens in Asthmatic Children Chest, November 1, 2007; 132(5): 1520 - 1525. [Abstract] [Full Text] [PDF]

				H. Dressel, C. Gross, D. de la Motte, J. Sultz, R. A. Jorres, and D. Nowak Educational intervention decreases exhaled nitric oxide in farmers with occupational asthma Eur. Respir. J., September 1, 2007; 30(3): 545 - 548. [Abstract] [Full Text] [PDF]

				B. Gaston Inhaled Corticosteroid Dose Reduction in Childhood Asthma: Is Nitrosopnea Informative? Am. J. Respir. Crit. Care Med., May 15, 2005; 171(10): 1065 - 1066. [Full Text] [PDF]

				G Roberts, C Hurley, A Bush, and G Lack Longitudinal study of grass pollen exposure, symptoms, and exhaled nitric oxide in childhood seasonal allergic asthma Thorax, September 1, 2004; 59(9): 752 - 756. [Abstract] [Full Text] [PDF]

				U. Frey, C. Kuehni, H. Roiha, M. Cernelc, B. Reinmann, J. H. Wildhaber, and G. L. Hall Maternal Atopic Disease Modifies Effects of Prenatal Risk Factors on Exhaled Nitric Oxide in Infants Am. J. Respir. Crit. Care Med., August 1, 2004; 170(3): 260 - 265. [Abstract] [Full Text] [PDF]

				S. B. Khatri, J. Hammel, M. S. Kavuru, S. C. Erzurum, and R. A. Dweik Temporal association of nitric oxide levels and airflow in asthma after whole lung allergen challenge J Appl Physiol, July 1, 2003; 95(1): 436 - 440. [Abstract] [Full Text] [PDF]

				Members of the Task Force:, E. Baraldi, J.C. de Jongste, B. Gaston, K. Alving, P.J. Barnes, H. Bisgaard, A. Bush, C. Gaultier, H. Grasemann, et al. Measurement of exhaled nitric oxide in children, 2001: E. Baraldi and J.C. de Jongste on behalf of the Task Force Eur. Respir. J., July 1, 2002; 20(1): 223 - 237. [Abstract] [Full Text] [PDF]

				J D Leuppi, S H Downs, S R Downie, G B Marks, and C M Salome Exhaled nitric oxide levels in atopic children: relation to specific allergic sensitisation, AHR, and respiratory symptoms Thorax, June 1, 2002; 57(6): 518 - 523. [Abstract] [Full Text] [PDF]

				T J Warke, P S Fitch, V Brown, R Taylor, J D M Lyons, M Ennis, and M D Shields Exhaled nitric oxide correlates with airway eosinophils in childhood asthma Thorax, May 1, 2002; 57(5): 383 - 387. [Abstract] [Full Text] [PDF]

				M. Van Den BERGE, H. A. M. KERSTJENS, R. J. MEIJER, D. M. DE REUS, G. H. KOETER, H. F. KAUFFMAN, and D. S. POSTMA Corticosteroid-induced Improvement in the PC20 of Adenosine Monophosphate Is More Closely Associated with Reduction in Airway Inflammation than Improvement in the PC20 of Methacholine Am. J. Respir. Crit. Care Med., October 1, 2001; 164(7): 1127 - 1132. [Abstract] [Full Text] [PDF]

				S. L. JONES, J. KITTELSON, J. O. COWAN, E. M. FLANNERY, R. J. HANCOX, C. R. MCLACHLAN, and D. R. TAYLOR The Predictive Value of Exhaled Nitric Oxide Measurements in Assessing Changes in Asthma Control Am. J. Respir. Crit. Care Med., September 1, 2001; 164(5): 738 - 743. [Abstract] [Full Text] [PDF]

				S. A. KHARITONOV and P. J. BARNES Exhaled Markers of Pulmonary Disease Am. J. Respir. Crit. Care Med., June 1, 2001; 163(7): 1693 - 1722. [Full Text] [PDF]

				E BARALDI and S ZANCONATO The labyrinth of asthma phenotypes and exhaled NO Thorax, May 1, 2001; 56(5): 333 - 335. [Full Text]

				F. BUCHVALD and H. BISGAARD FeNO Measured at Fixed Exhalation Flow Rate during Controlled Tidal Breathing in Children from the Age of 2 Yr Am. J. Respir. Crit. Care Med., March 1, 2001; 163(3): 699 - 704. [Abstract] [Full Text] [PDF]

				L.-P. Ho, F. T. Wood, A. Robson, J. A. Innes, and A. P. Greening Atopy Influences Exhaled Nitric Oxide Levels in Adult Asthmatics Chest, November 1, 2000; 118(5): 1327 - 1331. [Abstract] [Full Text] [PDF]

				L. M. van den TOORN, J.-B. PRINS, S. E. OVERBEEK, H. C. HOOGSTEDEN, and J. C. de JONGSTE Adolescents in Clinical Remission of Atopic Asthma Have Elevated Exhaled Nitric Oxide Levels and Bronchial Hyperresponsiveness Am. J. Respir. Crit. Care Med., September 1, 2000; 162(3): 953 - 957. [Abstract] [Full Text]

				J. C. de JONGSTE and K. ALVING Gas Analysis Am. J. Respir. Crit. Care Med., August 1, 2000; 162(2): S23 - 27. [Full Text] [PDF]

				M. SCOLLO, S. ZANCONATO, R. ONGARO, C. ZARAMELLA, F. ZACCHELLO, and E. BARALDI Exhaled Nitric Oxide and Exercise-Induced Bronchoconstriction in Asthmatic Children Am. J. Respir. Crit. Care Med., March 1, 2000; 161(3): 1047 - 1050. [Abstract] [Full Text] [PDF]

				P. Silkoff Recommendations for Standardized Procedures for the Online and Offline Measurement of Exhaled Lower Respiratory Nitric Oxide and Nasal Nitric Oxide in Adults and Children---1999 . THIS OFFICIAL STATEMENT OF THE AMERICAN THORACIC SOCIETY WAS ADOPTED BY THE ATS BOARD OF DIRECTORS, JULY 1999 Am. J. Respir. Crit. Care Med., December 1, 1999; 160(6): 2104 - 2117. [Full Text]

				H. BISGAARD, L. LOLAND, and J. A. ØJ NO in Exhaled Air of Asthmatic Children Is Reduced by the Leukotriene Receptor Antagonist Montelukast Am. J. Respir. Crit. Care Med., October 1, 1999; 160(4): 1227 - 1231. [Abstract] [Full Text]